These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33565048)

  • 81. Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany.
    Eidt-Koch D; Mittendorf T; Greiner W
    BMC Pediatr; 2009 Aug; 9():55. PubMed ID: 19715563
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Health problems are more common, but less severe when measured using newer EQ-5D versions.
    Craig BM; Pickard AS; Lubetkin EI
    J Clin Epidemiol; 2014 Jan; 67(1):93-9. PubMed ID: 24075597
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Health-related quality of life in residents aged 18 years and older with and without disease: findings from the First Provincial Health Services Survey of Hunan, China.
    Deng X; Dong P; Zhang L; Tian D; Zhang L; Zhang W; Li L; Deng J; Ning P; Hu G
    BMJ Open; 2017 Sep; 7(9):e015880. PubMed ID: 28871016
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi.
    Ngwira LG; Maheswaran H; Verstraete J; Petrou S; Niessen L; Smith SC
    J Patient Rep Outcomes; 2023 Mar; 7(1):22. PubMed ID: 36892714
    [TBL] [Abstract][Full Text] [Related]  

  • 85. An EQ-5D-5L Value Set for Vietnam.
    Mai VQ; Sun S; Minh HV; Luo N; Giang KB; Lindholm L; Sahlen KG
    Qual Life Res; 2020 Jul; 29(7):1923-1933. PubMed ID: 32221805
    [TBL] [Abstract][Full Text] [Related]  

  • 86. In a Child's Shoes: Composite Time Trade-Off Valuations for EQ-5D-Y-3L with Different Proxy Perspectives.
    Lipman SA; Essers BAB; Finch AP; Sajjad A; Stalmeier PFM; Roudijk B
    Pharmacoeconomics; 2022 Dec; 40(Suppl 2):181-192. PubMed ID: 36255560
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L.
    Mott DJ; Devlin NJ; Kreimeier S; Norman R; Shah KK; Rivero-Arias O
    Pharmacoeconomics; 2022 Dec; 40(Suppl 2):129-137. PubMed ID: 36396877
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A new tool for creating personal and social EQ-5D-5L value sets, including valuing 'dead'.
    Sullivan T; Hansen P; Ombler F; Derrett S; Devlin N
    Soc Sci Med; 2020 Feb; 246():112707. PubMed ID: 31945596
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A Direct Comparison Between Discrete Choice With Duration and Composite Time Trade-Off Methods: Do They Produce Similar Results?
    Roudijk B; Jonker MF; Bailey H; Pullenayegum E
    Value Health; 2024 Jun; ():. PubMed ID: 38843979
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Health-related quality of life among Indian population: The EQ-5D population norms for India.
    Jyani G; Prinja S; Garg B; Kaur M; Grover S; Sharma A; Goyal A
    J Glob Health; 2023 Feb; 13():04018. PubMed ID: 36799239
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Developing the EQ-5D-5L Value Set for Uganda Using the 'Lite' Protocol.
    Yang F; Katumba KR; Roudijk B; Yang Z; Revill P; Griffin S; Ochanda PN; Lamorde M; Greco G; Seeley J; Sculpher M
    Pharmacoeconomics; 2022 Mar; 40(3):309-321. PubMed ID: 34841471
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Valuation of EQ-5D-3l Health States in Slovenia: VAS Based and TTO Based Value Sets.
    Prevolnik Rupel V; Srakar A; Rand K
    Zdr Varst; 2020 Mar; 59(1):8-17. PubMed ID: 32952698
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Italian population-based values of EQ-5D health states.
    Scalone L; Cortesi PA; Ciampichini R; Belisari A; D'Angiolella LS; Cesana G; Mantovani LG
    Value Health; 2013; 16(5):814-22. PubMed ID: 23947975
    [TBL] [Abstract][Full Text] [Related]  

  • 94. UK Valuation of EQ-5D-5L, a Generic Measure of Health-Related Quality of Life: A Study Protocol.
    Rowen D; Mukuria C; Bray N; Carlton J; Cooper S; Longworth L; Meads D; O'Neill C; Yang Y
    Value Health; 2023 Nov; 26(11):1625-1635. PubMed ID: 37722593
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Preliminary findings of an investigation into the relationship between national culture and EQ-5D value sets.
    Bailey H; Kind P
    Qual Life Res; 2010 Oct; 19(8):1145-54. PubMed ID: 20496167
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Preference heterogeneity in health valuation: a latent class analysis of the Peru EQ-5D-5L values.
    Karim S; Craig BM; Tejada RA; Augustovski F
    Health Qual Life Outcomes; 2023 Jan; 21(1):1. PubMed ID: 36593473
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol.
    Hansen TM; Helland Y; Augestad LA; Rand K; Stavem K; Garratt A
    BMJ Open; 2020 Jun; 10(6):e034683. PubMed ID: 32532768
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada.
    Xie F; Pullenayegum E; Gaebel K; Bansback N; Bryan S; Ohinmaa A; Poissant L; Johnson JA;
    Med Care; 2016 Jan; 54(1):98-105. PubMed ID: 26492214
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Experience-based health state valuation using the EQ VAS: a register-based study of the EQ-5D-3L among nine patient groups in Sweden.
    Teni FS; Burström K; Devlin N; Parkin D; Rolfson O;
    Health Qual Life Outcomes; 2023 Apr; 21(1):34. PubMed ID: 37038172
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of Best-Worst Scaling.
    Dalziel K; Catchpool M; García-Lorenzo B; Gorostiza I; Norman R; Rivero-Arias O
    Pharmacoeconomics; 2020 May; 38(5):499-513. PubMed ID: 31974830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.